Livforsakringsbolaget Skandia Omsesidigt Raises Stock Holdings in CVS Health Co. (NYSE:CVS)

Livforsakringsbolaget Skandia Omsesidigt increased its position in CVS Health Co. (NYSE:CVS) by 2.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,503 shares of the pharmacy operator’s stock after buying an additional 1,150 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in CVS Health were worth $3,434,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in CVS. Weik Capital Management boosted its position in shares of CVS Health by 0.7% during the 1st quarter. Weik Capital Management now owns 17,600 shares of the pharmacy operator’s stock valued at $1,781,000 after acquiring an additional 120 shares during the last quarter. FCA Corp TX boosted its position in shares of CVS Health by 0.6% during the 1st quarter. FCA Corp TX now owns 20,109 shares of the pharmacy operator’s stock valued at $2,035,000 after acquiring an additional 122 shares during the last quarter. Arvest Trust Co. N A boosted its position in shares of CVS Health by 1.2% during the 4th quarter. Arvest Trust Co. N A now owns 11,157 shares of the pharmacy operator’s stock valued at $1,040,000 after acquiring an additional 131 shares during the last quarter. SOA Wealth Advisors LLC. boosted its position in shares of CVS Health by 4.9% during the 4th quarter. SOA Wealth Advisors LLC. now owns 2,859 shares of the pharmacy operator’s stock valued at $226,000 after acquiring an additional 133 shares during the last quarter. Finally, Apella Capital LLC raised its holdings in CVS Health by 4.2% during the 4th quarter. Apella Capital LLC now owns 3,378 shares of the pharmacy operator’s stock valued at $272,000 after buying an additional 136 shares during the period. 80.66% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Prem S. Shah sold 29,473 shares of the firm’s stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now owns 39,765 shares in the company, valued at $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.24% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. HSBC assumed coverage on CVS Health in a report on Friday, December 22nd. They set a “buy” rating and a $94.00 price target on the stock. Piper Sandler increased their price target on CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Friday, March 15th. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a report on Monday, February 26th. Barclays assumed coverage on CVS Health in a report on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price target on the stock. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $87.00 price target on shares of CVS Health in a report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $89.44.

CVS Health Stock Down 0.7 %

Shares of CVS Health stock traded down $0.45 during trading on Wednesday, hitting $68.58. 8,098,555 shares of the stock traded hands, compared to its average volume of 10,906,099. The firm has a market cap of $86.44 billion, a P/E ratio of 10.69, a price-to-earnings-growth ratio of 0.91 and a beta of 0.52. The company has a current ratio of 0.86, a quick ratio of 0.63 and a debt-to-equity ratio of 0.77. CVS Health Co. has a 52-week low of $64.41 and a 52-week high of $83.25. The stock’s fifty day simple moving average is $75.68 and its 200 day simple moving average is $73.77.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 EPS for the quarter, beating the consensus estimate of $2.01 by $0.11. The firm had revenue of $93.81 billion for the quarter, compared to analyst estimates of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same quarter last year, the firm posted $1.99 earnings per share. On average, equities analysts predict that CVS Health Co. will post 8.32 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 annualized dividend and a dividend yield of 3.88%. CVS Health’s dividend payout ratio is currently 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.